Browsing by Author Bird, R

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2008Consensus guidelines on anti-beta 2 glycoprotein I testing and reportingAdelstein, Stephen; Baumgart, Karl; Bird, R; Brighton, T A; Empson, M; Favaloro, Emmanuel J.; Gillis, David; Hendle, M J; Laurent, R; Mallon, D; Pollock, W; Smith, S; Steele, R H; Wilson, Robert J.; Wong, R. C. W.; Central Clinical School: MedicineConsensus guidelines on anti-beta 2 glycoprotein I testing and reporting, Pathology, vol.40, 1, 2008,pp 58-63
2017Evaluation of clinical coding data to determine causes of critical bleeding in patients receiving massive transfusion: a bi-national, multicentre, cross-sectional studyIsbister, James; Andrianopoulos, N.; Aoki, N; Badami, K; Bird, R; Cameron, Peter; Cole-Sinclair, M; Hurn, C; McQuilten, Zoe K; Phillips, Louise; Stevenson, L; Wood, Erica M; Zatta, Amanda J; Northern Clinical School: MedicineEvaluation of clinical coding data to determine causes of critical bleeding in patients receiving massive transfusion: a bi-national, multicentre, cross-sectional study, Transfusion Medicine (Online), vol.27, 2, 2017,pp 114-121
2003Recombinant activated factor VII for the treatment of life-threatening haemorrhageCoyle, Luke; Eikelboom, John; Ward, Christopher; Bird, R; Blythe, D; et, al; Gan, E; Harvey, M; Isbister, J; Leahy, M; McIlroy, D; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; Medicine Faculty OfficeRecombinant activated factor VII for the treatment of life-threatening haemorrhage, Blood Coagulation & Fibrinolysis, vol.14,(8),2003,pp 713-717